Should I buy Certara, Inc. (CERT) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Certara, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barclays | 25 % | -16.5 % | 8 | $8 -11% |
| Credit Suisse | 0 % | -14.9 % | 5 | — |
✅ Reasons to believe
- Few solid positives from analysts right now: of 7 ratings, only 2 buys, and the median price target ($8) is -5% below the price ($8). Caution prevails.
⚠️ Reasons to hesitate
- Even the most reliable firm on CERT, Barclays (25% hit rate, 8 scored calls), only targets $8 (call made on August 5, 2026, maturing on August 5, 2027) (-11%) in its most recent call, and $16 (call made on October 2, 2025, maturing on October 2, 2026) (+90%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 7 ratings, 5 are neutral.
- Limited upside: the median target is only -5% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on CERT
Median target $8 (-5%) · 7 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Certara, Inc. now?
We won't decide for you. The facts: 29% of analysts rate it a buy, median target $8 (-5%), and Barclays (most reliable on CERT, 25%) targets $8. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Certara, Inc.?
The stated upside is small: the median target ($8) sits just -5% from the price ($8) (most reliable on CERT: Barclays, 25%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Certara, Inc. still worth investing in?
It depends on the gap between the price ($8) and its estimated value: analysts target $8 on median (-5%), with 29% buys (most reliable on CERT: Barclays, 25%). Cross-check with their real reliability on CERT and the cautions above. Information, not advice.
What's the main risk in buying CERT?
Even the most reliable firm on CERT, Barclays (25% hit rate, 8 scored calls), only targets $8 (call made on August 5, 2026, maturing on August 5, 2027) (-11%) in its most recent call, and $16 (call made on October 2, 2025, maturing on October 2, 2026) (+90%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Certara, Inc. profile (consensus, analyst reliability, price target, performance).